Leerink Partners Reiterates Outperform Rating on Applied Therapeutics (APLT)
Tweet Send to a Friend
Leerink Partners analyst Joseph P. Schwartz reiterated an Outperform rating and $14.00 price target on Applied Therapeutics (NASDAQ: APLT).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
